Pantheon Vision has announced a strategic partnership with EyeDeal Medical to co-develop a bioengine...

Alcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech compan...

Bausch + Lomb has initiated a voluntary recall of specific intraocular lenses (IOLs) from its enVist...

Alsanza GmbH, a company known for its innovative ophthalmic products, continues to draw attention to...

Character Biosciences has closed an oversubscribed $93 million Series B financing round, which will ...

Nanoscope Therapeutics has announced the publication of clinical data on vision restoration in patie...

Surrozen has announced a strategic shift in its pipeline, transitioning its Wnt signaling expertise ...

Unity Biotechnology has announced topline results from its Phase 2b ASPIRE clinical trial, evaluatin...

Bausch + Lomb has released new findings from a Phase 4 clinical study evaluating Miebo (perfluorohex...

Opthea Limited has announced that its global Phase 3 clinical trial, known as COAST (Combination OPT...